Grants for For profit organizations other than small businesses - Health

This funding opportunity provides resources for researchers to establish collaborative teams focused on innovative breast cancer research, ultimately aiming to improve prevention, diagnosis, and treatment for Service Members, Veterans, and the general public.

This funding opportunity provides financial support to organizations that will establish training centers and support hubs to improve the skills and job flexibility of direct care workers in New York, addressing the growing demand for Personal Care Aides, Home Health Aides, and Certified Nursing Assistants.

This Annual Program Statement (APS) publicizes the intention of the United States Government (USG), as represented by the USAID Bureau for Global Health (GH), to fund one or multiple awards to address the overarching APS program purpose to strengthen the generation and utilization of social and behavior change (SBC) evidence to improve the uptake and continuation of healthy behaviors. This APS document outlines the goal, purpose, expected results, and priorities of the Social and Behavior Change (SBC) Research project, and may result in multiple awards issued under subsequent APS Rounds. Note: when referencing SBC Research in this document, it is referring to the full portfolio of possible awards under this overall purpose. This document is an umbrella APS and will not solicit concept papers or applications. Prospective applicants will be provided a fair opportunity to develop and submit competitive concept papers to USAID for potential funding via Rounds under this APS.

This grant opportunity allows Skilled Nursing Facilities (SNFs), non-profit organizations, consumer advocacy organizations, and more to apply for funding to implement projects to improve the lives of SNF residents. Examples of projects include, but are not limited to, developing and implementing methods to increase Person-Centered Care, Infection Control Training, implementing technology to prevent resident falls, and more. Examples of projects that will not be approved for CMP funding include, but are not limited to, research-only projects, projects with an indirect benefit to nursing residents, capital improvements to a facility, duplication of CMS requirements, and paying for nursing home staff salaries. Applicants must use the template provided on the CDPH website. Projects may vary in length up to a maximum of 36 months. Award size is dependent on project scope and request and funding availability. There is no stated limit to the amount of funds an applicant can request. Keywords: Civil Money Penalty, CMP, CDPH, CMS, Skilled Nursing Facility, Reinvestment, Public Health, SNF

This funding opportunity supports collaborative pilot studies using advanced microphysiological systems to explore new approaches in understanding and treating type 2 diabetes, inviting a diverse range of applicants from various sectors.

This funding opportunity provides financial support to established researchers to mentor emerging scientists in sleep and circadian research, particularly those facing barriers to accessing research experiences.

This funding opportunity supports the development of innovative research infrastructure to advance interdisciplinary studies on aging, encouraging collaborations that address complex aging-related issues and health disparities, particularly among women.

This funding opportunity supports innovative projects that develop new technologies for recording and modulating neural activity, aimed at enhancing our understanding of the nervous system through live-animal experimentation.

This funding opportunity provides $1 million to support a national coordinating center that will enhance collaboration, education, and research initiatives in nonmalignant hematology, targeting a diverse range of eligible institutions.

The Alliance for Pediatric Device Innovation (APDI) is offering grants up to $50,000 for pediatric medical devices aimed at improving the monitoring, diagnosis, or treatment of youth substance use disorders and addiction. Up to $150,000 in total grant funds are available for distribution. Eligible applicants include inventors from established businesses, startups, and academic researchers with commercializable device concepts that address unmet pediatric needs. The goal is to support the development of devices that can be commercialized, with an emphasis on bridging the gap between prototyping and FDA approval, marketing, and sales. Proposals should focus on innovations such as AI-based diagnostic tools, digital therapeutics, wearable devices, and neuromodulation therapies. The application deadline is July 30, 2024, and winners will be announced on August 15, 2024.

This funding opportunity provides financial support for institutions and organizations to create and manage a resource that supplies human tissues and organs for biomedical research, benefiting studies on various diseases and health conditions.

This funding opportunity provides financial support to small businesses and organizations developing innovative medical technologies and digital health solutions to improve health outcomes.

This funding opportunity provides financial support to states and organizations for developing a coordinated care model that improves health services for children with serious, long-term medical conditions.

The "Facilitating Preclinical and Early Phase Human Studies for New Therapeutics" grant aims to fund research that advances new treatments from preclinical stages to first-in-human trials for aging-related conditions, excluding neurodegenerative and Alzheimer's diseases, with a focus on improving injury repair in older adults and defining clear milestones for progress monitoring.

This funding opportunity provides financial support for research and public health initiatives aimed at combating infectious diseases in Kenya, while enhancing local research capabilities and collaboration with the Kenya Medical Research Institute.

The STRIPE program grant is designed to fund pre-clinical research that explores how radiopharmaceutical therapy affects cancer cells and their environment, with the aim of developing new targeting strategies and informing the design of future RPT-based clinical trials.

This funding opportunity supports collaborative research consortia focused on understanding the brain and body mechanisms involved in excessive alcohol use and Alcohol Use Disorder, aiming to improve prevention and intervention strategies.

The IDEA Fund program is a state-sponsored venture capital initiative that utilizes public funding (both state and federal) to drive economic development within the state. The primary focus of this program is to foster innovation and support technology-driven entrepreneurial endeavors that contribute to the state’s overall economic development growth. MTC’s Venture Capital Program was created to accelerate private venture capital investment in Missouri-based start-up companies and to increase the overall investment impact of third-party investments. The Venture Capital Program supports technology startups through matching equity or convertible debt investments up to $2,000,000 for the purpose of scaling the business to attract additional venture capital. Since 2010, MTC has invested over $49 million in more than 150 early-stage Missouri-based high-growth technology-focused companies. Since 2018, our portfolio companies have gone on to raise over $1.6 billion in additional private capital.

This funding opportunity provides financial support to Sacramento-based nonprofit cultural organizations and for-profit creative businesses to develop workforce training and internship programs for underserved youth and young adults aged 16-24.

This funding opportunity provides financial support to organizations working in India, the Philippines, and Vietnam to improve tuberculosis prevention, diagnosis, treatment, and surveillance efforts in these high-burden countries.